FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - Reuters
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxOb2M0aXZtM3RvVDBpVnc2V3I2ZXpWc2Q3aVJzY3R5OWw3M0NlOEN4cGExc1liYmh4Mkt6TzBrRjh6YTlVT0tFbzk5aFZnRTAxcUxhSWplX0E2aVdBRWt0bVdJNzR4WGFtM2c2Vi1ZdC13R21qOXFNSkVXeXJnaE9FQTFya2pOY0hCZ3dGVXZfQXZHTUxHSG5YaHBpWkxEUjVQdzhJcUxGeFJyRGhwRGtTTXlVcmxvaGZ0bUR2S3NxYlUxNTZCMG5CNzhPY3YzWTQ?oc=5" target="_blank">FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Boots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMReport highlights flaws in ADHD and autism care
There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found.
October 9, 2026 at 01:52 PMHumana surges after topping 2027 Medicare star ratings - Reuters
Humana surges after topping 2027 Medicare star ratings Reuters
October 9, 2026 at 01:33 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMMost Medicare Advantage drug plan enrollees in high-quality plans, US government says - Reuters
Most Medicare Advantage drug plan enrollees in high-quality plans, US government says Reuters
October 8, 2026 at 11:29 PM